The global biopharma industry has become increasingly reliant on smaller biotech firms to help provide new products to feed its R&D pipelines. In the battle for deals, what does it take to come out a winner? The fourth edition of BCG’s partnering study helps illuminate the attributes of an ideal partner—and which companies are living up to these expectations. The survey rates and ranks more than 20 top pharmaceutical and biotech firms in terms of their perceived partnering capabilities.
Articles, Insight
Biopharma partnering: Perspectives from BCG’s latest biotech and pharma partnering study
Posted on 13 June 2011
2 Responses to “Biopharma partnering: Perspectives from BCG’s latest biotech and pharma partnering study”
Leave a Reply
Home | Reports | Services | Insight | News | Events | Scorecard | About us | Terms & conditions | Subscribe | Contact us
© 2012 Wildwood Ventures Ltd. 
Please send an e-copy of Biopharma partnering: Perspectives from BCG’s latest biotech and pharma partnering study
Thank you
Hello Pamela, thanks for your message! If you click on the link in the article above, it will generate an email direct to BCG for you to request the study direct. We don’t actually have it here to supply direct but I’m sure they’ll happily supply you with that. Thanks and kind regards, Claire.